Company Valuation: Exosens

Data adjusted to current consolidation scope
Fiscal Period: December 2024 2025 2026 2027 2028
Market Cap 1 986.7 2,459 3,111 - -
Change - 149.26% 26.48% - -
Enterprise Value (EV) 1 1,131 2,657 3,266 3,202 3,123
Change - 134.98% 22.93% -1.96% -2.47%
P/E 31.9x 57.7x 39.4x 27.1x 22.7x
PBR 2.39x 5.51x 6.07x 5.16x 4.38x
PEG 0x 1.5x 0.5x 0.6x 1.2x
Capitalization / Revenue 2.5x 5.25x 5.56x 4.91x 4.35x
EV / Revenue 2.87x 5.68x 5.84x 5.05x 4.37x
EV / EBITDA 9.54x 17.5x 18x 15.3x 12.7x
EV / EBIT 11.9x 20.8x 21.7x 18x 15.3x
EV / FCF 20.4x 46.4x 53.2x 39x 28.9x
FCF Yield 4.9% 2.16% 1.88% 2.56% 3.46%
Dividend per Share 2 0.1 0.3 0.3797 0.519 0.6306
Rate of return 0.51% 0.62% 0.62% 0.85% 1.03%
EPS 2 0.61 0.84 1.55 2.254 2.694
Distribution rate 16.4% 35.7% 24.5% 23% 23.4%
Net sales 1 394.1 468.2 559.6 633.8 715.4
EBITDA 1 118.5 151.6 181.5 209.4 245.3
EBIT 1 95.3 127.6 150.7 178 204.7
Net income 1 30.7 42.7 80.03 113.6 134.9
Net Debt 1 144.1 197.7 155.7 91.73 12.71
Reference price 2 19.43 48.45 61.10 61.10 61.10
Nbr of stocks (in thousands) 50,783 50,762 50,911 - -
Announcement Date 3/3/25 23/2/26 - - -
1EUR in Million2EUR
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
39.43x5.84x17.99x0.62% 3.49B
35.1x6.49x27.21x0.59% 318B
30.56x2.86x16.99x1.55% 248B
25.44x1.69x12.57x1.81% 168B
34.86x5.08x21.31x0.98% 162B
33.03x3.62x16.42x1.25% 153B
-662.61x1.79x40.4x-.--% 152B
16.62x1.62x11.63x2.77% 117B
41.69x9.4x29.14x0.23% 91.55B
19.52x1.66x13.56x1.9% 89.61B
Average -38.64x 4.00x 20.72x 1.17% 150.34B
Weighted average by Cap. -39.61x 3.94x 21.56x 1.16%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Exosens

Historical PBR trend

Valuation ratios - PBR - Exosens

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Exosens

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Exosens


Year-on-year evolution of the Yield

Valuation ratios - Yield - Exosens